Beam Therapeutics Inc.
BEAM
$25.17
-$0.15-0.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 370.38% | -16.61% | -12.34% | -10.74% | -163.27% |
| Total Depreciation and Amortization | 4.13% | 1.55% | -0.68% | 1.79% | 1.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -889.79% | 14.47% | -40.58% | -19.46% | 59.02% |
| Change in Net Operating Assets | -390.84% | 72.17% | 113.28% | 32.90% | 34.14% |
| Cash from Operations | -9.07% | 7.54% | 7.90% | -4.15% | -156.54% |
| Capital Expenditure | -25.72% | -217.76% | -59.92% | -25.72% | 17.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.24% | 169.24% | -287.00% | -139.14% | 27.10% |
| Cash from Investing | -14.15% | 165.83% | -294.77% | -133.97% | 28.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -45.24% | 14.49% | 362.08% | 15,299.45% | -89.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.24% | 32.73% | 733.83% | 16,240.32% | -89.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.39% | 77.24% | -5,422.76% | 262.60% | -80.01% |